Modern Research Center for Traditional Chinese Medicine of Shanxi University, Taiyuan 030006, PR China.
Modern Research Center for Traditional Chinese Medicine of Shanxi University, Taiyuan 030006, PR China.
J Ethnopharmacol. 2014 Feb 3;151(2):912-20. doi: 10.1016/j.jep.2013.12.001. Epub 2013 Dec 12.
Bu-zhong-yi-qi-tang (BT) is a classical formula for the treatment of spleen-qi descending, visceroptosis with hyposplenic qi, uterine prolapse, and rectal prolapse due to chronic diarrhea in traditional Chinese medicine (TCM) and has been identified as an effective drug for the treatment of TCM spleen-qi deficiency in clinical practice. The present study aimed to investigate the restorative effect and the potential mechanisms of Bu-zhong-yi-qi-tang in a rat spleen-qi deficiency model using (1)H-NMR-based metabonomics.
The rat spleen-qi deficiency model was established as follows: oral administration of Radix Rhei extract (equivalent to 10g/kg body weight of the crude drug), loaded swimming, and starvation for 24h. Each of these treatments was administered consecutively every three days. Sixty male SD rats were randomly divided into five groups, and three of the groups received a different oral dose of the aqueous extract of Bu-zhong-yi-qi-tang during the last seven days of the three-week experimental period. The body weight and motor behavior of the rats were measured and recorded once a week. The endogenous metabolites in the plasma were analyzed using NMR in conjunction with multivariate and statistical techniques. In addition, the liver and spleen were removed and weighed.
All of the rats in the spleen-qi deficiency group presented pasty loose stools, inactiveness, grouping, a decrease in swimming endurance, and lackluster, loose, and disorderly behavior in addition to a significant decrease in body weight, spleen weight, and liver weight. In contrast, the abovementioned demonstrations were reversed to a certain extent in the rats treated with Bu-zhong-yi-qi-tang compared with the model group (p<0.05, p<0.01). A significant separation was determined between the control and model groups in the PCA score plot, which indicates that the spleen-qi deficiency model was successfully duplicated. The changes in the levels of endogenous metabolites in the plasma included lower levels of valine, leucine, and O-acetyl-glycoprotein and a higher concentration of lactate in the spleen-qi deficiency group compared with the control group. Treatment with Bu-zhong-yi-qi-tang at least partially returned the levels of these metabolites to the normal levels.
The restorative effects of Bu-zhong-yi-qi-tang in rats with spleen-qi deficiency were confirmed, and four endogenous metabolites were identified as potential biomarkers of the symptoms of spleen-qi deficiency and most likely play roles in the changes observed in certain metabolic pathways, such as the energy, protein, and glycolytic metabolisms.
ETHNOPHARMACOLOGICAL 相关性:补中益气汤(BT)是一种经典的方剂,用于治疗中医中的脾虚泄泻、内脏下垂、脾气虚、子宫脱垂和直肠脱垂,并已被确定为治疗中医脾虚的有效药物。本研究旨在通过(1)H-NMR 基于代谢组学的方法,探讨补中益气汤在脾虚大鼠模型中的修复作用及其潜在机制。
采用大黄提取物(相当于 10g/kg 生药)灌胃、载泳、禁食 24h 的方法建立大鼠脾虚模型。每三天连续进行一次处理。60 只雄性 SD 大鼠随机分为五组,其中三组在为期三周的实验期的最后七天给予不同剂量的补中益气汤水提取物。每周测量并记录一次大鼠的体重和运动行为。采用 NMR 结合多元统计技术分析血浆中的内源性代谢物。此外,还切除并称重肝脏和脾脏。
脾虚组大鼠均出现糊状稀便、呆滞、成群、游泳耐力下降、精神萎靡、毛发凌乱等表现,体重、脾脏重量和肝脏重量均显著减轻。相比之下,补中益气汤治疗组大鼠的上述表现均有一定程度的逆转,与模型组相比(p<0.05,p<0.01)。PCA 得分图上,控制组和模型组之间存在明显的分离,表明脾虚模型成功复制。与对照组相比,脾虚组大鼠血浆内源性代谢物水平发生变化,包括缬氨酸、亮氨酸和 O-乙酰糖蛋白水平降低,乳酸水平升高。补中益气汤治疗至少部分恢复了这些代谢物的水平。
证实了补中益气汤对脾虚大鼠的修复作用,并鉴定出 4 种内源性代谢物可能是脾虚症状的潜在生物标志物,它们可能在某些代谢途径的变化中发挥作用,如能量、蛋白质和糖酵解代谢。